| Literature DB >> 26098382 |
Remigijus Vasiliauskas1,2, Dongfei Liu2, Salvatore Cito2, Hongbo Zhang2, Mohammad-Ali Shahbazi2, Tiina Sikanen2, Linas Mazutis1,3, Hélder A Santos2.
Abstract
Herein, we report the production of monodisperse hollow microparticles from three different polymers, namely, pH-responsive acetylated dextran and hypromellose acetate succinate and biodegradable poly(lactic-co-glycolic acid), at varying polymer concentrations using a poly(dimethylsiloxane)-based microfluidic device. Hollow microparticles formed during solvent diffusion into the continuous phase when the polymer close to the interface solidified, forming the shell. In the inner part of the particle, phase separation induced solvent droplet formation, which dissolved the shell, forming a hole and a hollow-core particle. Computational simulations showed that, despite the presence of convective recirculation around the droplet, the mass-transfer rate of the solvent dissolution from the droplet to the surrounding phase was dominated by diffusion. To illustrate the potential use of hollow microparticles, we simultaneously encapsulated two anticancer drugs and investigated their loading and release profiles. In addition, by utilizing different polymer shells and polymer concentrations, the release profiles of the model drugs could be tailored according to specific demands and applications. The high encapsulation efficiency, controlled drug release, unique hollow microparticle structure, small particle size (<7 μm), and flexibility of the polymer choice could make these microparticles advanced platforms for pulmonary drug delivery.Entities:
Keywords: PDMS microfluidics; drug delivery; hollow microparticles; multidrug encapsulation; solvent diffusion
Mesh:
Substances:
Year: 2015 PMID: 26098382 DOI: 10.1021/acsami.5b04824
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229